Assessing Measurable Residual Disease in Chronic Myeloid Leukemia. BCR-ABL1 IS in the
BCR-ABL
IS
chronic myeloid leukemia
mathematical modeling
treatment free remission
Journal
Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867
Informations de publication
Date de publication:
2019
2019
Historique:
received:
30
04
2019
accepted:
20
08
2019
entrez:
15
10
2019
pubmed:
15
10
2019
medline:
15
10
2019
Statut:
epublish
Résumé
Chronic myelogenous leukemia (CML) is a malignancy of the myeloid cell lineage characterized by a recurrent chromosomal abnormality: the Philadelphia chromosome, which results from the reciprocal translocation of the chromosomes 9 and 22. The Philadelphia chromosome contains a fusion gene called BCR-ABL1. The BCR-ABL1 codes for an aberrantly functioning tyrosine kinase that drives the malignant proliferation of the founding clone. The advent of tyrosine kinase inhibitors (TKI) represents a landmark in the treatment of CML, that has led to tremendous improvement in the remission and survival rates. Since the introduction of imatinib, the first TKI, several other TKI have been approved that further broadened the arsenal against CML. Patients treated with TKIs require sensitive monitoring of BCR-ABL1 transcripts with quantitative real-time polymerase chain reaction (qRT-PCT), which has become an essential part of managing patients with CML. In this review, we discuss the importance of the BCR-ABL1 assay, and we highlight the growing importance of BCR-ABL1 dynamics. We also introduce a mathematical correction for the BCR-ABL1 assay that could help homogenizing the use of the ABL1 as a control gene. Finally, we discuss the growing body of evidence concerning treatment-free remission. Along with the continuous improvement in the therapeutic arsenal against CML, the molecular monitoring of CML represents the
Identifiants
pubmed: 31608223
doi: 10.3389/fonc.2019.00863
pmc: PMC6768007
doi:
Types de publication
Journal Article
Langues
eng
Pagination
863Informations de copyright
Copyright © 2019 Moisoiu, Teodorescu, Parajdi, Pasca, Zdrenghea, Dima, Precup, Tomuleasa and Soverini.
Références
Pathol Biol (Paris). 2009 Jul;57(5):388-91
pubmed: 18387753
Blood Adv. 2018 Nov 13;2(21):2922-2936
pubmed: 30396912
J Clin Oncol. 2008 Jul 10;26(20):3358-63
pubmed: 18519952
Blood. 2014 Feb 27;123(9):1309-18
pubmed: 24345751
Am J Hematol. 2015 Apr;90(4):282-7
pubmed: 25530131
Blood. 2009 Dec 3;114(24):4944-53
pubmed: 19779040
Leukemia. 2018 May;32(5):1222-1228
pubmed: 29479070
Blood. 2004 Dec 1;104(12):3739-45
pubmed: 15315971
Leukemia. 2012 Sep;26(9):2096-102
pubmed: 22446502
Blood. 2016 Jun 2;127(22):2742-50
pubmed: 27006386
J Clin Oncol. 2018 Jan 20;36(3):231-237
pubmed: 29091516
Blood. 2008 Oct 15;112(8):3330-8
pubmed: 18684859
Clin Cancer Res. 2006 Dec 15;12(24):7374-9
pubmed: 17189410
Cancer Cell. 2014 Sep 8;26(3):428-442
pubmed: 25132497
Blood. 2004 Oct 1;104(7):2204-5
pubmed: 15377577
Cancer. 2009 Dec 1;115(23):5382-93
pubmed: 19739234
Drugs. 2017 Jan;77(1):85-96
pubmed: 28032244
Fundam Clin Pharmacol. 2013 Dec;27(6):690-7
pubmed: 23113675
Best Pract Res Clin Haematol. 2001 Sep;14(3):553-71
pubmed: 11640869
Blood. 2013 Oct 24;122(17):3086-8
pubmed: 24159169
Leukemia. 2003 Dec;17(12):2474-86
pubmed: 14562124
J Clin Invest. 2007 Aug;117(8):2030-2
pubmed: 17671635
N Engl J Med. 2006 Dec 7;355(23):2408-17
pubmed: 17151364
Leukemia. 2014 Oct;28(10):1988-92
pubmed: 24798484
Ann Oncol. 2017 Jul 1;28(suppl_4):iv41-iv51
pubmed: 28881915
Blood. 2014 Jul 24;124(4):519-29
pubmed: 24740813
Blood. 2009 Sep 3;114(10):2168-71
pubmed: 19589924
Leuk Lymphoma. 2015 Feb;56(2):546-7
pubmed: 25012945
J Clin Invest. 2011 Jan;121(1):396-409
pubmed: 21157039
Cancer Cell. 2009 Nov 6;16(5):401-12
pubmed: 19878872
Leukemia. 2015 Sep;29(9):1832-8
pubmed: 26118315
Blood. 2003 Jul 1;102(1):276-83
pubmed: 12623848
Cancer. 2017 Nov 15;123(22):4391-4402
pubmed: 28743165
Blood. 2016 Feb 11;127(6):666-7
pubmed: 26869304
Expert Rev Mol Diagn. 2013 Sep;13(7):749-62
pubmed: 24063401
Methods Mol Biol. 2011;730:33-61
pubmed: 21431633
Expert Rev Hematol. 2016 May;9(5):419-24
pubmed: 26853281
J Clin Oncol. 2012 Oct 1;30(28):3486-92
pubmed: 22949154
J Clin Oncol. 2005 Jun 20;23(18):4100-9
pubmed: 15867198
Blood. 2009 Feb 19;113(8):1619-30
pubmed: 18827185
Clin Cancer Res. 2007 Oct 15;13(20):6136-43
pubmed: 17947479
Blood. 2008 Dec 15;112(13):4839-42
pubmed: 18818391
N Engl J Med. 2017 Mar 9;376(10):917-927
pubmed: 28273028
Blood. 2012 Jul 26;120(4):737-47
pubmed: 22653972
Int J Hematol. 2012 Feb;95(2):209-13
pubmed: 22262141
J Clin Oncol. 2012 Jan 20;30(3):232-8
pubmed: 22067393
Chin Med J (Engl). 2009 Jun 20;122(12):1413-7
pubmed: 19567163
Clin Cancer Res. 2014 Jan 15;20(2):310-22
pubmed: 24166905
Blood. 2016 Feb 11;127(6):703-12
pubmed: 26603839
Blood. 2008 Dec 1;112(12):4437-44
pubmed: 18716134
Curr Hematol Malig Rep. 2014 Mar;9(1):1-8
pubmed: 24395452
Haematologica. 2013 Jul;98(7):e78-9
pubmed: 23753022
Blood. 2014 Jul 24;124(4):511-8
pubmed: 24859364
Blood. 2007 Apr 15;109(8):3496-9
pubmed: 17192396
Leuk Res. 2017 Jun;57:109-111
pubmed: 28359029
J Mol Diagn. 2013 Sep;15(5):565-76
pubmed: 23810242
PLoS One. 2014 Sep 09;9(9):e106250
pubmed: 25203717
Br J Pharmacol. 2009 Oct;158(4):1153-64
pubmed: 19785662
Leukemia. 2006 Jun;20(6):1061-6
pubmed: 16642048
Leukemia. 2017 May;31(5):1108-1116
pubmed: 27890936
Blood. 2008 Apr 15;111(8):4022-8
pubmed: 18256322
Radiat Res. 2013 Mar;179(3):361-82
pubmed: 23398354
J Clin Oncol. 2008 Oct 10;26(29):4806-13
pubmed: 18645191
N Engl J Med. 2003 Mar 13;348(11):994-1004
pubmed: 12637609
J Clin Oncol. 2002 Jan 1;20(1):214-20
pubmed: 11773172
Blood. 2012 Feb 9;119(6):1501-10
pubmed: 22184410
Clin Lymphoma Myeloma Leuk. 2016 Jun;16(6):e85-94
pubmed: 27101984
Clin Lymphoma Myeloma Leuk. 2016 Aug;16 Suppl:S96-S100
pubmed: 27131622
Leukemia. 2016 May;30(5):1044-54
pubmed: 26837842
J Clin Oncol. 2009 Sep 1;27(25):4204-10
pubmed: 19652056
Expert Rev Hematol. 2018 Apr;11(4):269-272
pubmed: 29448857
Leukemia. 2016 Aug;30(8):1638-47
pubmed: 27133824
Nat Med. 2006 Oct;12(10):1181-4
pubmed: 17013383
Blood. 2017 Mar 2;129(9):1166-1176
pubmed: 28049640
J Clin Oncol. 2016 Jul 10;34(20):2333-40
pubmed: 27217448
N Engl J Med. 2003 Oct 9;349(15):1423-32
pubmed: 14534335
Leukemia. 2017 Nov;31(11):2398-2406
pubmed: 28804124
Ann Hematol. 2015 Apr;94 Suppl 2:S159-65
pubmed: 25814082
J Clin Oncol. 2011 Apr 20;29(12):1634-42
pubmed: 21422420
Leukemia. 2017 Mar;31(3):585-592
pubmed: 27560111
J Hematol Oncol. 2018 Jun 20;11(1):84
pubmed: 29925402
Am J Hematol. 2016 Feb;91(2):252-65
pubmed: 26799612
N Engl J Med. 2006 Jun 15;354(24):2542-51
pubmed: 16775235
Blood. 2008 Jul 1;112(1):53-5
pubmed: 18403620
Blood. 2009 Sep 10;114(11):2232-5
pubmed: 19531657
Blood. 2007 Jan 1;109(1):58-60
pubmed: 16973963